Product Information
CHOLESTYRAMINE PACKET is a generic product labeled by Ascend Laboratories, LLC, priced at $0.7724 per EA under NDC 67877029860. Its NADAC has been published 232 times since Dec 22, 2021.
FDA first approved this application on Oct 19, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
4 g/8.78g
Manufacturer
Ascend Laboratories, LLCNDC
67877029860
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CHOLESTYRAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA211856FDA Approved
10/19/2021
TE Code
AB
On Market Since
10/20/2021
Pharmacological Classes
Price Statistics
The NADAC for CHOLESTYRAMINE PACKET has been published 232 times since Dec 22, 2021, and over the history we have for it it has declined 37.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7724 per EA |
|---|---|
| All-time high | $1.2760 (Feb 16, 2022) |
| All-time low | $0.5806 (Apr 17, 2024) |
| 52-week high | $0.9390 |
| 52-week low | $0.6721 |
| Median price | $0.8751 |
| Average price | $0.8865 |
| Largest weekly change | +34.2% (Jun 19, 2024) |
| Weeks tracked | 232 |
| Tracking since | Dec 22, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the cholestyramine powder for suspension market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CHOLESTYRAMINE PACKET?
The current National Average Drug Acquisition Cost (NADAC) for CHOLESTYRAMINE PACKET, manufactured by Ascend Laboratories, LLC, is $0.7724 per EA (NDC 67877029860), effective Aug 19, 2026.
How has the price of CHOLESTYRAMINE PACKET changed over time?
Over the history we have for it, the NADAC for CHOLESTYRAMINE PACKET has declined 37.4%. It has been tracked across 232 weekly CMS publications since Dec 22, 2021.
What are the highest and lowest recorded NADAC prices for CHOLESTYRAMINE PACKET?
Since Dec 22, 2021, the NADAC for CHOLESTYRAMINE PACKET has ranged from a low of $0.5806 (Apr 17, 2024) to a high of $1.2760 (Feb 16, 2022), with a median of $0.8751 per EA.
Are there cheaper alternatives to CHOLESTYRAMINE PACKET?
No other NADAC-published product currently shares the active ingredient and strength of CHOLESTYRAMINE PACKET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CHOLESTYRAMINE PACKET?
CHOLESTYRAMINE PACKET (NDC 67877029860) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.